Clo/asp8-pmk-mcs

Intervention

1 paper2 findings

  • 1 lab in 2 countries
  • Animals1

Outcomes

2

Bone formation

upin mice1

1 study
  1. Clo/asp8-pmk-mcs increase bone formation in mice.

    “reduce osteoclast-related parameters and serum bone resorption markers, and enhance bone formation.”

    Animalsovariectomized micecloperastine-loaded Asp8-modified methionine/lysine-based ROS-responsive polyethylene glycol micellesbone

    Drug-carrying particles reduced bone loss in mice

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)11 Oct 2026

Bone loss

downin mice1

1 study
  1. Clo/asp8-pmk-mcs decrease bone loss in mice.

    “In ovariectomized mice, Clo/Asp8-PMK-MCs attenuate ovariectomy-induced bone loss”

    Animalsovariectomized micecloperastine-loaded Asp8-modified methionine/lysine-based ROS-responsive polyethylene glycol micellesbone

    Drug-carrying particles reduced bone loss in mice

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)11 Oct 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 in 12 months
Advanced Science

Drug-carrying particles reduced bone loss in mice

In an animal experiment, drug-carrying particles preserved bone structure and enhanced bone formation in mice whose ovaries had been removed.In an animal experiment, drug-carrying particles preserved bone structure and enhanced bone formation in mice whose ovaries had been removed.

Experiments in miceBones and joints